AIM ImmunoTech annual gross profit
2009
2010
2011
2012
2013
2014
2022
2023
2024
2025
AIM ImmunoTech Gross Profit Growth & History (AIM)
AIM ImmunoTech's gross profit was −$40,000 for fiscal 2025.
View full AIM ImmunoTech company overviewAIM ImmunoTech annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$40,000 | −$179,000 | — |
| 2024 | 2024-12-31 | $139,000 | −$21,000 | −13.13% |
| 2023 | 2023-12-31 | $160,000 | $19,000 | +13.48% |
| 2022 | 2022-12-31 | $141,000 | — | — |
| 2014 | 2014-12-31 | −$1.1M | $30,000 | — |
| 2013 | 2013-12-31 | −$1.1M | $692,000 | — |
| 2012 | 2012-12-31 | −$1.8M | −$894,000 | — |
| 2011 | 2011-12-31 | −$882,000 | $324,000 | — |
| 2010 | 2010-12-31 | −$1.2M | −$733,000 | — |
| 2009 | 2009-12-31 | −$473,000 | — | — |
AIM ImmunoTech quarterly gross profit
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $18,000 | $12,000 | +200.00% |
| Q4 2025 | 2025-12-31 | −$19,000 | — | — |
| Q3 2025 | 2025-09-30 | −$42,000 | — | — |
| Q2 2025 | 2025-06-30 | $15,000 | — | — |
| Q1 2025 | 2025-03-31 | $6,000 | — | — |
| Q3 2015 | 2015-09-30 | −$330,000 | −$69,000 | — |
| Q2 2015 | 2015-06-30 | −$460,000 | −$202,000 | — |
| Q1 2015 | 2015-03-31 | −$336,000 | −$89,000 | — |
| Q4 2014 | 2014-12-31 | −$288,000 | −$168,000 | — |
| Q3 2014 | 2014-09-30 | −$261,000 | −$45,000 | — |
| Q2 2014 | 2014-06-30 | −$258,000 | $341,000 | — |
| Q1 2014 | 2014-03-31 | −$247,000 | −$98,000 | — |
| Q4 2013 | 2013-12-31 | −$120,000 | $340,000 | — |
| Q3 2013 | 2013-09-30 | −$216,000 | $733,000 | — |
| Q2 2013 | 2013-06-30 | −$599,000 | −$440,000 | — |
| Q1 2013 | 2013-03-31 | −$149,000 | $59,000 | — |
| Q4 2012 | 2012-12-31 | −$460,000 | −$69,000 | — |
| Q3 2012 | 2012-09-30 | −$949,000 | −$777,000 | — |
| Q2 2012 | 2012-06-30 | −$159,000 | $9,000 | — |
| Q1 2012 | 2012-03-31 | −$208,000 | −$57,000 | — |
| Q4 2011 | 2011-12-31 | −$391,000 | — | — |
| Q3 2011 | 2011-09-30 | −$172,000 | −$26,000 | — |
| Q2 2011 | 2011-06-30 | −$168,000 | $119,000 | — |
| Q1 2011 | 2011-03-31 | −$151,000 | — | — |
| Q3 2010 | 2010-09-30 | −$146,000 | — | — |
| Q2 2010 | 2010-06-30 | −$287,000 | — | — |
AIM ImmunoTech gross profit trends
Between the periods ended 2009-12-31 and 2025-12-31, AIM ImmunoTech's gross profit increased from −$473,000 to −$40,000, a change of $433,000. The latest reported quarter, Q1 2026, shows $18,000.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AIM ImmunoTech source filings ↗